10/22/03 One year after transformation of the “Idea of MitoProd” into the “MitoProd project”, the MitoProd Team is helped in its efforts and obtains the means necessary for being able to change the MitoProd project into a company. Supported by ANVAR, CNRS, Victor Segalen Bordeaux 2 University, Bordeaux Unitec and Biotechnica, MitoProd is housed at Institut de Biochimie et Génétique Cellulaires – CNRS – Bordeaux. MitoProd is developing a new technology to produce in large scale and at low cost, customized Ribonucleic Acids (RNA). This technology was invented and patented by Dr Jean-Paul di Rago’s research team. The IRA agreement is completing the material and financial supports of the ANVAR, the CNRS and the Victor Segalen Bordeaux 2 University that weights 225.000 €, by bringing a reimbursable funding of 45.000 €, that will allows the financing of studies required for setting going of the company.
Ending of the current pilot studies, the development of the first commercial partnerships and the constitution of the first financial investments will mark the next steps of MitoProd growth.